Hot Features
プレミアム
ANI Pharmaceuticals Inc (ANIP)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | Mr. Patrick D. Walshインサイダー | -13.97k | 1.13M | 売り | 80.63 - 80.75 | 38.43k | -26.66% |
| 2026-05-12 | Mr. Thomas Andrew RowlandSenior VP & Head of Established Brands | -459.00 | 36.36k | 売り | 79.21 | 38.27k | -1.19% |
| 2026-05-12 | Mr. Ori GutwergSVP of Generics | -2.77k | 220.37k | 売り | 79.50 | 78.70k | -3.40% |
| 2026-05-11 | Mr. Nikhil LalwaniPresident, CEO & Director | -55.00k | 4.27M | 売り | 77.57 | 349.89k | -13.58% |
| 2026-05-13 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -500.00 | 39.08k | Automatic Disposition | 78.16 | 78.39k | -0.63% |
| 2026-04-13 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -500.00 | 38.98k | Automatic Disposition | 77.95 | 78.89k | -0.63% |
| 2026-03-13 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -500.00 | 36.31k | Automatic Disposition | 72.62 | 79.39k | -0.63% |
| 2026-03-11 | Mr. Thomas Andrew RowlandSenior VP & Head of Established Brands | -4.77k | 357.47k | 売り | 74.91 | 38.73k | -10.97% |
| 2026-03-13 | Mr. Christopher K. MutzSenior Vp & Head of Rare Disease | -3.16k | 226.53k | Automatic Disposition | 71.64 | 91.31k | -3.35% |
| 2026-03-06 | Mr. Christopher K. MutzSenior Vp & Head of Rare Disease | -5.72k | 424.62k | Automatic Disposition | 74.18 - 74.22 | 94.47k | -5.71% |
| 2026-03-07 | Mr. Christopher K. MutzSenior Vp & Head of Rare Disease | -3.31k | 245.37k | Sale to Issuer | 74.04 | 94.47k | -3.39% |
| 2026-03-07 | Mr. Nikhil LalwaniPresident, CEO & Director | -17.06k | 1.26M | Sale to Issuer | 74.04 | 404.89k | -4.04% |
| 2026-03-07 | Mr. Ori GutwergSVP of Generics | -3.31k | 245.37k | Sale to Issuer | 74.04 | 81.47k | -3.91% |
| 2026-03-06 | Ms. Krista L. DavisSenior VP & Chief HR Officer | -6.57k | 488.47k | Automatic Disposition | 74.13 - 75.00 | 51.95k | -11.23% |
| 2026-03-07 | Mr. Stephen P. CareySenior VP of Finance & CFO | -5.15k | 381.31k | Sale to Issuer | 74.04 | 180.39k | -2.78% |
| 2026-03-05 | Mr. Stephen P. CareySenior VP of Finance & CFO | -3.31k | 85.81k | Derivative Exercise and Sale | 49.51 - 75.42 | 185.54k | - |
| 2026-03-05 | Mr. Stephen P. CareySenior VP of Finance & CFO | -4.00k | 302.24k | 売り | 75.56 | 185.54k | -2.11% |
| 2026-03-02 | Mr. Christopher K. MutzSenior Vp & Head of Rare Disease | -417.00 | 30.86k | Automatic Disposition | 74.00 | 103.51k | -0.40% |
| 2026-03-03 | Mr. Ori GutwergSVP of Generics | -2.06k | 157.59k | 売り | 76.50 | 84.78k | -2.37% |
| 2026-03-03 | Mr. Patrick D. Walshインサイダー | -6.00k | 445.38k | 売り | 74.23 | 52.41k | -10.27% |
| 2026-02-28 | Mr. Thomas Andrew RowlandSenior VP & Head of Established Brands | -628.00 | 46.41k | Sale to Issuer | 73.90 | 43.50k | -1.42% |
| 2026-02-28 | Mr. Nikhil LalwaniPresident, CEO & Director | -12.22k | 902.84k | Sale to Issuer | 73.90 | 421.95k | -2.81% |
| 2026-02-28 | Mr. Christopher K. MutzSenior Vp & Head of Rare Disease | -2.22k | 164.13k | Sale to Issuer | 73.90 | 103.93k | -2.09% |
| 2026-02-28 | Mr. Ori GutwergSVP of Generics | -2.22k | 164.13k | Sale to Issuer | 73.90 | 86.84k | -2.49% |
| 2026-02-28 | Mr. Stephen P. CareySenior VP of Finance & CFO | -2.77k | 204.92k | Sale to Issuer | 73.90 | 189.54k | -1.44% |
| 2026-02-28 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -1.56k | 114.91k | Sale to Issuer | 73.90 | 79.89k | -1.91% |
| 2026-02-28 | Ms. Krista L. DavisSenior VP & Chief HR Officer | -1.56k | 114.91k | Sale to Issuer | 73.90 | 58.52k | -2.59% |
| 2026-02-28 | Mr. Chad GassertSVP of Corporate Development & Strategy | -2.22k | 164.13k | Sale to Issuer | 73.90 | 233.41k | -0.94% |
| 2026-02-19 | Ms. Krista L. DavisSenior VP & Chief HR Officer | -3.81k | 296.50k | Automatic Disposition | 77.53 - 77.99 | 49.26k | -7.19% |
| 2026-02-20 | Mr. Christopher K. MutzSenior Vp & Head of Rare Disease | -5.32k | 415.30k | Automatic Disposition | 78.02 | 84.84k | -5.90% |
| 2026-02-12 | Mr. Thomas Andrew RowlandSenior VP & Head of Established Brands | -1.05k | 80.93k | Sale to Issuer | 76.70 - 77.36 | 38.11k | -2.68% |
| 2026-02-12 | Mr. Christopher K. MutzSenior Vp & Head of Rare Disease | -7.03k | 538.30k | Automatic Disposition | 76.55 | 90.16k | -7.23% |
| 2026-02-12 | Mr. Christopher K. MutzSenior Vp & Head of Rare Disease | -5.58k | 429.27k | Sale to Issuer | 76.70 - 77.36 | 90.16k | -5.82% |
| 2026-02-12 | Mr. Nikhil LalwaniPresident, CEO & Director | -21.99k | 1.69M | Sale to Issuer | 76.70 - 77.36 | 358.57k | -5.78% |
| 2026-02-12 | Mr. Ori GutwergSVP of Generics | -3.66k | 282.20k | Sale to Issuer | 76.70 - 77.36 | 76.09k | -4.59% |
| 2026-02-12 | Mr. Chad GassertSVP of Corporate Development & Strategy | -3.33k | 256.16k | Sale to Issuer | 76.70 - 77.36 | 224.51k | -1.46% |
| 2026-02-12 | Ms. Krista L. DavisSenior VP & Chief HR Officer | -2.47k | 190.30k | Sale to Issuer | 76.70 - 77.36 | 53.08k | -4.45% |
| 2026-02-13 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -500.00 | 38.40k | Automatic Disposition | 76.80 | 67.55k | -0.73% |
| 2026-02-12 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -3.31k | 255.28k | Sale to Issuer | 76.70 - 77.36 | 67.55k | -4.68% |
| 2026-02-12 | Mr. Stephen P. CareySenior VP of Finance & CFO | -5.28k | 406.36k | Sale to Issuer | 76.70 - 77.36 | 170.08k | -3.01% |
| 2026-02-11 | Mr. Stephen P. CareySenior VP of Finance & CFO | -5.50k | 419.60k | Sale to Issuer | 76.25 | 175.36k | -3.04% |
| 2026-02-11 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -3.01k | 229.59k | Sale to Issuer | 76.25 | 71.36k | -4.05% |
| 2026-02-11 | Ms. Krista L. DavisSenior VP & Chief HR Officer | -3.02k | 230.05k | Sale to Issuer | 76.25 | 55.55k | -5.15% |
| 2026-02-11 | Mr. Chad GassertSVP of Corporate Development & Strategy | -4.27k | 325.51k | Sale to Issuer | 76.25 | 227.84k | -1.84% |
| 2026-02-11 | Mr. Ori GutwergSVP of Generics | -4.27k | 325.36k | Sale to Issuer | 76.25 | 79.76k | -5.08% |
| 2026-02-11 | Mr. Nikhil LalwaniPresident, CEO & Director | -30.66k | 2.34M | Sale to Issuer | 76.25 | 380.56k | -7.46% |
| 2026-02-11 | Mr. Christopher K. MutzSenior Vp & Head of Rare Disease | -4.55k | 346.63k | Sale to Issuer | 76.25 | 102.77k | -4.24% |
| 2026-02-11 | Mr. Thomas Andrew RowlandSenior VP & Head of Established Brands | -1.76k | 134.35k | Sale to Issuer | 76.25 | 39.16k | -4.31% |
| 2026-02-11 | Mr. Muthusamy ShanmugamHead of R&D, COO of New Jersey Operations & Director | -2.90k | 220.97k | Sale to Issuer | 76.25 | 71.42k | -3.90% |
| 2026-01-13 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -500.00 | 42.17k | Automatic Disposition | 84.33 | 74.37k | -0.67% |
| 2025-12-18 | Ms. Krista L. DavisSenior VP & Chief HR Officer | -1.62k | 133.65k | Automatic Disposition | 82.40 | 58.56k | -2.69% |
| 2025-12-12 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -400.00 | 32.93k | Automatic Disposition | 82.32 | 74.87k | -0.53% |
| 2025-12-05 | Dr. Renee P. TannenbaumIndependent Director | -1.80k | 146.07k | 売り | 81.15 | 25.16k | -6.68% |
| 2025-11-13 | Mr. Patrick D. Walshインサイダー | -8.64k | 750.90k | 売り | 86.88 | 58.41k | -12.89% |
| 2025-11-13 | Mr. Patrick D. Walshインサイダー | -3.00k | 0.00 | Other Disposition | - | 58.41k | -4.89% |
| 2025-11-12 | Mr. Chad GassertSVP of Corporate Development & Strategy | -14.64k | 1.30M | 売り | 89.07 | 232.11k | -5.93% |
| 2025-11-13 | Mr. Chad GassertSVP of Corporate Development & Strategy | -94.00 | 8.27k | 売り | 88.00 | 232.11k | -0.04% |
| 2025-11-13 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -400.00 | 34.91k | Automatic Disposition | 87.27 | 75.27k | -0.53% |
| 2025-10-13 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -400.00 | 36.04k | Automatic Disposition | 90.09 | 75.67k | -0.53% |
| 2025-09-19 | Ms. Krista L. DavisSenior VP & Chief HR Officer | -1,000.00 | 98.04k | Automatic Disposition | 98.04 | 60.19k | -1.63% |
| 2025-09-12 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -400.00 | 39.37k | Automatic Disposition | 98.42 | 76.07k | -0.52% |
| 2025-09-12 | Ms. Krista L. DavisSenior VP & Chief HR Officer | -1.71k | 167.08k | Sale to Issuer | 97.71 | 61.19k | -2.72% |
| 2025-09-03 | Mr. Antonio R. PeraIndependent Director | -7.29k | 692.30k | 売り | 94.94 | 22.66k | -24.35% |
| 2025-08-25 | Mr. Matthew J. LeonardIndependent Director | -2.53k | 229.09k | 売り | 90.62 | 6.86k | -26.92% |
| 2025-08-22 | Ms. Krista L. DavisSenior VP & Chief HR Officer | -1.76k | 160.61k | 売り | 91.10 | 62.90k | -2.73% |
| 2025-08-20 | Esjay Llc法人 | -100.00k | 9.04M | 売り | 90.27 - 90.44 | 431.92k | -18.80% |
| 2025-08-20 | Mr. Antonio R. PeraIndependent Director | -5.42k | 486.43k | 売り | 89.73 | 29.95k | -15.33% |
| 2025-08-18 | Ms. Jeanne A. ThomaIndependent Director | -21.54k | 1.92M | 売り | 88.87 - 89.76 | 23.41k | -47.93% |
| 2025-08-18 | Mr. Matthew J. LeonardIndependent Director | -6.94k | 611.64k | 売り | 88.17 | 9.39k | -42.48% |
| 2025-08-15 | Mr. Patrick D. Walshインサイダー | -9.00k | 801.45k | 売り | 89.05 | 70.05k | -11.39% |
| 2025-08-14 | Esjay Llc法人 | -100.00k | 8.82M | 売り | 87.15 - 89.48 | 531.92k | -15.82% |
| 2025-08-15 | Mr. Chad GassertSVP of Corporate Development & Strategy | -20.00k | 1.74M | 売り | 86.97 | 246.84k | -7.50% |
| 2025-08-12 | Mr. Thomas Andrew RowlandSenior VP & Head of Established Brands | -4.98k | 426.41k | 売り | 85.71 | 40.79k | -10.87% |
| 2025-08-12 | Mr. Nikhil LalwaniPresident, CEO & Director | -56.96k | 4.89M | 売り | 85.93 | 411.22k | -12.17% |
| 2025-08-12 | Mr. Ori GutwergSVP of Generics | -5.87k | 508.19k | 売り | 86.53 | 84.02k | -6.53% |
| 2025-08-13 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -400.00 | 35.55k | Automatic Disposition | 88.87 | 76.47k | -0.52% |
| 2025-08-12 | Mr. Stephen P. CareySenior VP of Finance & CFO | -50.00k | 1.98M | Derivative Exercise and Sale | 46.49 - 86.07 | 180.86k | - |
| 2025-08-12 | Mr. Thomas J. HaugheyIndependent Chairman of the Board | -19.34k | 1.66M | 売り | 85.93 | 36.52k | -34.62% |
| 2025-07-18 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -2.07k | 137.31k | Sale to Issuer | 66.30 | 76.87k | -2.62% |
| 2025-07-14 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -400.00 | 25.95k | Automatic Disposition | 64.88 | 78.95k | -0.50% |
| 2025-06-13 | Ms. Meredith W. CookSenior VP, General Counsel & Corporate Secretary | -400.00 | 24.55k | Automatic Disposition | 61.37 | 79.35k | -0.50% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
